Compass Therapeutics
CMPX
Compass Therapeutics (CMPX) news
Recent news
EU clears acquisition of BTZ by CM and Bunge
AInvest Wire · 2d agoCompass Therapeutics - To further engage with FDA on BLA submission for Tovecimig
AInvest Wire · Sep 22, 2026Compass Therapeutics - FDA recommends survival benefit trial before BLA submission for Tovecimig
AInvest Wire · Sep 22, 2026Compass Therapeutics provides regulatory update on Tovecimig in biliary tract cancer following FDA feedback
AInvest Wire · Sep 22, 2026Compass Therapeutics: $180 mln in cash and marketable securities at end of Q2 2026, which is expected to fund operations into 2028
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.